Skip to main content
Veterinary Medicines

Baytril flavour 250 mg Tabletten für große Hunde

Authorised
  • Enrofloxacin

Product identification

Medicine name:
Baytril flavour 250 mg Tabletten für große Hunde
Active substance:
  • Enrofloxacin
Target species:
  • Dog (large)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    250.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog (large)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Authorisation status:
  • Valid
Authorised in:
  • Austria
Available in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00857
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 4/01/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 4/01/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 4/01/2024

AT-puar-Baeeytril-flaeevoeeueer-250-mg-Taeebletten-fueer-groeesse-Hueende-800857-DE.pdf

German (PDF)
Published on: 18/10/2016
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."